Literature DB >> 6965773

The risk of Parkinson disease in Mediterranean people.

G Rosati, E Granieri, L Pinna, I Aiello, R Tola, P De Bastiani, A Pirisi, M C Devoto.   

Abstract

On the basis of previous epidemiologic studies, Parkinson disease was thought to be evenly distributed throughout the world. These studies, however, were conducted only on North European populations. The position with regard to the Mediterranean peoples was still unknown, and we therefore studied the frequency of Parkinson disease on the island of Sardinia, where some ethnic groups of the Mediterranean stock are represented. Based on 967 accepted cases, the prevalence 100,000 population on January 1, 1972, was 65.6; the average annual incidence for the period 1961 through 1971 was 4.9. These figures are one-half of the figures established for North Europeans. Our findings suggest racial differences in predisposition to Parkinson disease. Some Negroid features are present in Sardinians. If, as seems likely, Africans prove to be relatively unsusceptible to the disease, the risk for Sardinians and other Mediterranean ethnic groups might be intermediate between North Europeans and Africans.

Entities:  

Mesh:

Year:  1980        PMID: 6965773     DOI: 10.1212/wnl.30.3.250

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

1.  The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.

Authors:  R C Dodel; M Singer; R Köhne-Volland; T Szucs; B Rathay; E Scholz; W H Oertel
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

2.  Prescribing pattern and resource utilization of monoamine oxidase-B inhibitors in Parkinson treatment: comparison between rasagiline and selegiline.

Authors:  Luca Degli Esposti; Carlo Piccinni; Diego Sangiorgi; Flavio Nobili; Stefano Buda
Journal:  Neurol Sci       Date:  2015-10-16       Impact factor: 3.307

3.  Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.

Authors:  M C de Rijk; C Tzourio; M M Breteler; J F Dartigues; L Amaducci; S Lopez-Pousa; J M Manubens-Bertran; A Alpérovitch; W A Rocca
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

4.  Epidemiology of Parkinson disease in the city of Kolkata, India: a community-based study.

Authors:  S K Das; A K Misra; B K Ray; A Hazra; M K Ghosal; A Chaudhuri; T Roy; T K Banerjee; D K Raut
Journal:  Neurology       Date:  2010-10-12       Impact factor: 9.910

Review 5.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

6.  Epidemiology of Parkinson's disease--an overview.

Authors:  R J Marttila; U K Rinne
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

7.  Parkinson's disease in a Scottish city.

Authors:  W J Mutch; I Dingwall-Fordyce; A W Downie; J G Paterson; S K Roy
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-22

8.  The prevalence of Parkinson's disease in Portugal. A population approach.

Authors:  J A Dias; M M Felgueiras; J P Sanchez; J M Gonçalves; J M Falcäo; Z P Pimenta
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

9.  Burden of Parkinson's disease in Sicily: a health administrative database study.

Authors:  Calogero Edoardo Cicero; Salvatore Scondotto; Alessandra Vincenza Allotta; Giovanni De Luca; Giuseppe Murolo; Alessandra Nicoletti; Mario Zappia
Journal:  Neurol Sci       Date:  2021-07-14       Impact factor: 3.307

Review 10.  Systematic review of the prevalence and incidence of Parkinson's disease in Asia.

Authors:  Weerasak Muangpaisan; Hiroyuki Hori; Carol Brayne
Journal:  J Epidemiol       Date:  2009-10-03       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.